Figure 6From: The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma Proposed sequence of events. Recap of the proposed sequence of biological consequences of adding each component of therapy, culminating in local tumor necrosis, widespread complement deposition, and enhanced survival when RT is added to chemotherapy and IDO-blockade.Back to article page